Product Program year 2025 Source: CMS Open Payments

General - Pelvic Organ Prolapse

Device General - Pelvic Organ Prolapse_URO

Open in the dashboard

General payments

$130,126

63 payments

Research payments

$0

0 payments

Through program year 2025, $130,126 in general payments and $0 in research payments were reported against General - Pelvic Organ Prolapse (General - Pelvic Organ Prolapse_URO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $126,441 39
2022 General $3,685 24

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $130,126 63 payments
Top recipients General payments · program year 2025
  1. John Myrga Urology · San Francisco, CA $50,000 40% · 1 payment
  2. Kian Ahmadieh Urology · Gilbert, AZ $15,000 12% · 1 payment
  3. Miriam Raffeld Obstetrics & Gynecology · Philadelphia, PA $15,000 12% · 1 payment
  4. Anh Nguyen Urology · New York, NY $15,000 12% · 1 payment
  5. Uci Medical Center Teaching hospital · CA $14,300 11% · 2 payments

The top 5 of 33 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $94,567 86% · 13 practitioners
  2. Obstetrics & Gynecology $15,042 14% · 3 practitioners
  3. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $736 <1% · 7 practitioners
  4. Urogynecology and Reconstructive Pelvic Surgery Urology $148 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $64,300 51% · 2 recipients
  2. Pennsylvania $15,400 12% · 2 recipients
  3. Arizona $15,000 12% · 1 recipient
  4. New York $15,000 12% · 1 recipient
  5. Tennessee $5,178 4% · 1 recipient

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

63 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record